Biochemical marker discovery, testing and evaluation for facilitating OA drug discovery and development.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Drug Discovery Today

• Publication date

  2017-10-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.drudis.2017.10.008PMID 29038075
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Osteoarthritis Year in Review 2016: biomarkers (biochemical markers).

  2017cited by this paper
• Osteoarthritis year in review 2016: imaging.

  2017cited by this paper
• Synovial fluid pro-inflammatory profile differs according to the characteristics of knee pain.

  2017cited by this paper
• Pain prediction by serum biomarkers of bone turnover in people with knee osteoarthritis: an observational study of TRAcP5b and cathepsin K in OA.

  2017cited by this paper
• Biomarker of extracellular matrix remodelling C1M and proinflammatory cytokine interleukin 6 are related to synovitis and pain in end-stage knee osteoarthritis patients

  2017cited by this paper
• The Need for Predictive, Prognostic, Objective and Complementary Blood-Based Biomarkers in Osteoarthritis (OA)

  2016cited by this paper
• Fibulin-3 fragments are prognostic biomarkers of osteoarthritis incidence in overweight and obese women.

  2016cited by this paper
• Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA Biomarkers Consortium

  2016cited by this paper
• Relationship between synovial fluid biomarkers of articular cartilage metabolism and the patient's perspective of outcome depends on the severity of articular cartilage damage following ACL trauma

  2016cited by this paper
• Association between biomarkers of tissue inflammation and progression of osteoarthritis: evidence from the Rotterdam study cohort

  2016cited by this paper
• Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage–bone crosstalk

  2016cited by this paper
• Osteoarthritis year in review 2015: soluble biomarkers and the BIPED criteria.

  2016cited by this paper
• Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: lessons learned from failures and opportunities for the future.

  2016cited by this paper
• Identification of clinical phenotypes in knee osteoarthritis: a systematic review of the literature

  2016cited by this paper
• Osteoarthritis biomarkers derived from cartilage extracellular matrix: Current status and future perspectives.

  2016cited by this paper
• Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment?

  2016cited by this paper
• Sensitization and Serological Biomarkers in Knee Osteoarthritis Patients With Different Degrees of Synovitis

  2016cited by this paper
• Synovitis biomarkers: ex vivo characterization of three biomarkers for identification of inflammatory osteoarthritis

  2015cited by this paper
• Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use.

  2015cited by this paper
• The Effect of Protease Inhibitors on the Induction of Osteoarthritis-Related Biomarkers in Bovine Full-Depth Cartilage Explants

  2015cited by this paper
• OA phenotypes, rather than disease stage, drive structural progression--identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA.

  2015cited by this paper
• The ability of systemic biochemical markers to reflect presence, incidence, and progression of early-stage radiographic knee and hip osteoarthritis: data from CHECK.

  2015cited by this paper
• Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials.

  2015cited by this paper
• Serum cartilage oligomeric matrix protein and development of radiographic and painful knee osteoarthritis. A community-based cohort of middle-aged women

  2015cited by this paper
• Osteoarthritis joint pain: the cytokine connection.

  2014cited by this paper
• Osteoarthritis year in review 2014: we need more biochemical biomarkers in qualification phase.

  2014cited by this paper
• An ARGS-aggrecan assay for analysis in blood and synovial fluid.

  2014cited by this paper
• Large scale meta-analysis of urinary C-terminal telopeptide, serum cartilage oligomeric protein and matrix metalloprotease degraded type II collagen and their role in prevalence, incidence and progression of osteoarthritis.

  2014cited by this paper
• Cartilage Turnover Reflected by Metabolic Processing of Type II Collagen: A Novel Marker of Anabolic Function in Chondrocytes

  2014cited by this paper
• Osteoarthritis--a case for personalized health care?

  2014cited by this paper
• Association between adiponectin and cartilage degradation in human osteoarthritis.

  2014cited by this paper
• Alpha C‐Telopeptide of Type I Collagen Is Associated With Subchondral Bone Turnover and Predicts Progression of Joint Space Narrowing and Osteophytes in Osteoarthritis

  2014cited by this paper
• Biomarkers of cartilage and surrounding joint tissue.

  2014cited by this paper
• Usefulness of urinary CTX-II and NTX-I in evaluating radiological knee osteoarthritis : the Matsudai knee osteoarthritis survey

  2014cited by this paper
• Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnover.

  2014cited by this paper
• Effect of tocilizumab combined with methotrexate on circulating biomarkers of synovium, cartilage, and bone in the LITHE study.

  2014cited by this paper
• Quantitation OF ARGS aggrecan fragments in synovial fluid, serum and urine from osteoarthritis patients.

  2014cited by this paper
• Meta-analysis identifies loci affecting levels of the potential osteoarthritis biomarkers sCOMP and uCTX-II with genome wide significance

  2014cited by this paper
• Synovitis in Knee Osteoarthritis Assessed by Contrast-enhanced Magnetic Resonance Imaging (MRI) is Associated with Radiographic Tibiofemoral Osteoarthritis and MRI-detected Widespread Cartilage Damage: The MOST Study

  2014cited by this paper
• The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments?

  2013cited by this paper
• MRI-based semiquantitative scoring of joint pathology in osteoarthritis

  2013cited by this paper
• Serum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: A novel diagnostic and prognostic biomarker

  2013cited by this paper
• Extended report: Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial

  2013cited by this paper
• Changes in Serum Biomarkers of Cartilage Turnover After Anterior Cruciate Ligament Injury

  2013cited by this paper
• Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind randomised, placebo-controlled trial

  2013cited by this paper
• Republished: Value of biomarkers in osteoarthritis: current status and perspectives

  2013cited by this paper
• Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review.

  2012cited by this paper
• Biological markers in osteoarthritis.

  2012cited by this paper
• Cross-sectional and predictive associations between plasma adipokines and radiographic signs of early-stage knee osteoarthritis: data from CHECK.

  2012cited by this paper
• Inhibition of cathepsin K reduces cartilage degeneration in the anterior cruciate ligament transection rabbit and murine models of osteoarthritis.

  2012cited by this paper
• Increased synovial fluid visfatin is positively linked to cartilage degradation biomarkers in osteoarthritis

  2012cited by this paper
• Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage.

  2012cited by this paper
• The role of synovitis in osteoarthritis pathogenesis.

  2012cited by this paper
• Magnetic resonance imaging of subchondral bone marrow lesions in association with osteoarthritis.

  2012cited by this paper
• Osteochondral alterations in osteoarthritis.

  2012cited by this paper
• Serum resistin level is associated with radiographic changes in hand osteoarthritis: cross-sectional study.

  2012cited by this paper
• Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis.

  2011cited by this paper
• Osteoarthritis: an update with relevance for clinical practice

  2011cited by this paper
• Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM--increased serum CIIM in subjects with severe radiographic osteoarthritis.

  2011cited by this paper
• Application of Biomarkers in the Development of Drugs Intended for the Treatment of Osteoarthritis OARSI FDA Osteoarthritis Biomarkers Working Group

  2011cited by this paper
• Temporal relationship between serum adipokines, biomarkers of bone and cartilage turnover, and cartilage volume loss in a population with clinical knee osteoarthritis.

  2011cited by this paper
• Macroscopic and histopathologic analysis of human knee menisci in aging and osteoarthritis.

  2011cited by this paper
• Inflammation in osteoarthritis

  2011cited by this paper
• The Normal Synovium

  2011cited by this paper
• The knee meniscus: structure-function, pathophysiology, current repair techniques, and prospects for regeneration.

  2011cited by this paper
• The path to personalized medicine.

  2010cited by this paper
• Adiponectin is a potential catabolic mediator in osteoarthritis cartilage

  2010cited by this paper
• Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis

  2010cited by this paper
• Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria.

  2010cited by this paper
• Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis - the effect of sex, Kellgren-Lawrence (KL) score, Body Mass Index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation

  2010cited by this paper
• Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers--are they the cause or the consequence of the disease?

  2010cited by this paper
• Identifying different osteoarthritis phenotypes through epidemiology.

  2010cited by this paper
• Application of biochemical markers in development of drugs for treatment of osteoarthritis

  2010cited by this paper
• Relation of synovitis to knee pain using contrast-enhanced MRIs

  2010cited by this paper
• Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis

  2009cited by this paper
• Association between radiographic features of knee osteoarthritis and pain: results from two cohort studies

  2009cited by this paper
• Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers

  2009cited by this paper
• Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis.

  2008cited by this paper
• Bone marrow edema pattern in advanced hip osteoarthritis: quantitative assessment with magnetic resonance imaging and correlation with clinical examination, radiographic findings, and histopathology

  2008cited by this paper
• Should subchondral bone turnover be targeted when treating osteoarthritis?

  2008cited by this paper
• Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies

  2008cited by this paper
• Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage.

  2008cited by this paper
• Fragmentation of decorin, biglycan, lumican and keratocan is elevated in degenerate human meniscus, knee and hip articular cartilages compared with age-matched macroscopically normal and control tissues

  2008cited by this paper
• Correlation of the development of knee pain with enlarging bone marrow lesions on magnetic resonance imaging.

  2007cited by this paper
• Biological markers in osteoarthritis

  2007cited by this paper
• MMP and non-MMP-mediated release of aggrecan and its fragments from articular cartilage: a comparative study of three different aggrecan and glycosaminoglycan assays.

  2007cited by this paper
• Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis

  2007cited by this paper
• Osteoclasts prefer aged bone

  2007cited by this paper
• An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice

  2006cited by this paper
• Classification of osteoarthritis biomarkers: a proposed approach.

  2006cited by this paper
• Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum

  2006cited by this paper
• Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis. Contribution of joint tissues to their articular production.

  2006cited by this paper
• Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study

  2005cited by this paper
• Biochemical and mechanical properties of subchondral bone in osteoarthritis.

  2004cited by this paper
• Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration.

  2004cited by this paper
• The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model.

  2004cited by this paper
• Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) Study

  2004cited by this paper
• Evidence of altered bone turnover, vitamin D and calcium regulation with knee osteoarthritis in female twins.

  2003cited by this paper
• The role of bone metabolism in osteoarthritis

  2003cited by this paper
• Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy.

  2000cited by this paper

• The inflammatory endotype in osteoarthritis: Reflections from the 2024 OARSI clinical trials symposium (CTS) with a special emphasis on feasibility for clinical development

  2025cites this paper
• Establishment of a Prediction Model to Diagnose the End-stage Knee Osteoarthritis Based on a Significant Difference in Ferroptosis-Related Genes in Chondrocytes

  2025cites this paper
• Sodium tanshinone IIA sulfonate alleviates osteoarthritis through targeting SIRT1

  2025cites this paper
• Research Progress of Osteoarthritis Treatment by Low Intensity Pulsed Ultrasound

  2025cites this paper
• Advancing osteoarthritis research: the role of AI in clinical, imaging and omics fields

  2025cites this paper
• Terminologies and definitions used to classify patients with osteoarthritis: a scoping review

  2025cites this paper
• LIPUS Promotes Calcium Oscillation and Enhances Calcium Dependent Autophagy of Chondrocytes to Alleviate Osteoarthritis

  2025cites this paper
• From biochemical markers to molecular endotypes of osteoarthritis: a review on validated biomarkers

  2024influential citation
• Serum biomarkers in prednisolone-treated hand osteoarthritis patients

  2022cites this paper
• L-Glutamine alleviates osteoarthritis by regulating lncRNA-NKILA expression through the TGF-β1/SMAD2/3 signalling pathway

  2022cites this paper
• The future of deep phenotyping in osteoarthritis: How can high throughput omics technologies advance our understanding of the cellular and molecular taxonomy of the disease?

  2021cites this paper
• Blood and urine biomarkers in osteoarthritis – an update on cartilage associated type II collagen and aggrecan markers

  2021cites this paper
• The perspectives of intra-articular therapy in the management of osteoarthritis

  2020cites this paper
• SIRT4 suppresses the inflammatory response and oxidative stress in osteoarthritis.

  2020cites this paper
• The acute and long‐term impact of physical activity on biochemical markers and MRI measures in osteoarthritis—Perspectives for clinical osteoarthritis research

  2020cites this paper
• Translational strategies in drug development for knee osteoarthritis.

  2020cites this paper
• Pharmacotherapeutic considerations and options for the management of osteoarthritis in women

  2020cites this paper
• Low‐intensity pulsed ultrasound inhibits VEGFA expression in chondrocytes and protects against cartilage degeneration in experimental osteoarthritis

  2020cites this paper
• Blood and urinary collagen markers in osteoarthritis: markers of tissue turnover and disease activity

  2019cites this paper
• Biochemical markers in osteoarthritis with lessons learned from osteoporosis.

  2019influential citation
• Osteoarthritis phenotypes and novel therapeutic targets.

  2019cites this paper
• Molecular taxonomy of osteoarthritis for patient stratification, disease management and drug development: biochemical markers associated with emerging clinical phenotypes and molecular endotypes

  2019cites this paper
• Dehydroepiandrosterone: Molecular mechanisms and therapeutic implications in osteoarthritis.

  2018cites this paper
• Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics

  2018cites this paper